Whatever the Numbers Say, Guess Who Keeps Paying More for Rx?
January produced another price hike party from drug makers. But some data indicate prescription prices are actually falling. For consumers? Same as it ever was, or worse.
January produced another price hike party from drug makers. But some data indicate prescription prices are actually falling. For consumers? Same as it ever was, or worse.
A decade after introducing pharmacy transparency to the market, it was time to make our brand identity as distinctive as our solution.
For 20 years, the promised future of personalized healthcare seemed elusive. Not anymore, thanks to innovative partners who are driving better outcomes.
Soon all commercial, Medicare Advantage and employer-sponsored health plans will be required to publish prices for a variety of services, including prescription drugs. A boon for consumers, and an opportunity for plans.
Even the best-laid plans are hard to execute in our entrenched system. Our CEO Michael Rea reflects on the end of a promising joint venture by three of America’s largest employers.
Proposed rules that flew under most people’s radar could be major wins for transparency, consumerism and competition. Our CEO believes they might be the most meaningful changes in two decades.
Please rock the vote on Election Day. Just don’t expect Washington to rock the boat when it comes to high drug prices. We have a solution that works, and we appreciate your vote.
Whatever the next normal looks like, and whenever we get there, our goal is still the same: make the world a better place for our members and clients.
We caught a big price hike for the active ingredient in hydroxycholorquine, hailed by some as an effective COVID-19 treatment. Whatever the outcome on tablet prices, our solution is already helping affected members.
Our founder and CEO shares why World Autism Awareness Day carries so much meaning and purpose—for his family, and the entire Rx Savings Solutions team.